While the overall number of ILCs in melanoma patient peripheral blood (PB) was lower than in controls, the percentage of ILC1s (gated as Lin- CD127+ cKit- CRTH2-) among ILCs, increased in PB as well as in tumor-infiltrated lymph nodes (TILN). This evidence concerns the gene KIT and neoplasm.